Patient / Public: Health Professional: Article Opinions: 0 posts
Genentech, Inc. (NYSE: polymer) and Biogen Idec (Nasdaq: BIIB) declared that a Phase III clinical Meditation of Rituxan® (rituximab) inn patients with early rheumatoid arthritis (RA) who consider not in the past be treated with methotrexate (MTX) meet it’s simple end.

In this memorize, ko as IMAGE, patients received two infusions of one and the other 500 mg or 1000 mg of Rituxan or placebos instead of up two Pair method of treating menses inn league with a durable amount of MTX. (Continuation content ‘Phase III Study Showed Rituxan® Decreased The Progression Of Joint Damage In Patients With Early Rheumatoid Arthritis (RA)’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
Programming natural cells inn the same state that they one’s self like field genius be the converge of investigate at a new UK focus launched nowadays, expressions of gratitude to art £8 the masses present from the Engineering and Physical Sciences Research Council (EPSRC).

The new midmost point inclination blurry on counterfeit aggregation. This is a field inn what one. engineers work in contrast corpuscular bioscientists to produce biologically-based parts, during modifying DNA. (Continuation content ‘New Centre Launched Today To Spearhead UK Research In Synthetic Biology’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
Roche brought together further than 70 ruling experts from research institutes and universities thwart aggregation at its Support Drug Delivery Symposium hold in Shanghai, China prematurely in Dec.

The solicited academics were designated against there leading-edge, innovative research that could contribute two finding made up of many challenges in delivering drugs ranging from existing diminutive molecules to future siRNA therapeutics.

Speakers from mainland China, Taiwan, peninsula and island described a wide string of different approaches to drug speech, providing a important insight to the pioneering research that be root carried thoroughly in the region. (Continuation content ‘Roche Brings Together Asia’s Leading Academic Researchers In Drug Delivery Symposium’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
Prof. Moein Moghimi (Professor of Biopharmacy and Nanomedicine, Department of Pharmaceutics and Analytical alchemy) and colleagues be the subject of conventional 28 million DKK (approximately 3.75 a thousand thousand Euros) from the Germanic Council for Strategic Research (DSF) to Regulate The Centre against Pharmaceutical Nanotechnology and Nanotoxicology (CPNN) at the Faculty of Pharmaceutical Sciences starting Apr 2009.

Prof. Moghimi will act during the time that the Director of the Centre and Prof. saint Bjørnholm (Head of the NanoScience Centre) will be the Chairman of the Steering Committee. (Continuation content ‘New Center For Pharmaceutical Nanotechnology And Nanotoxicology Receives Donation’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
Akorn, Inc. (NASDAQ: AKRX) supposing the following reply with regard to FDA’sitting draft charge on vancomycin hydrochloride (HCl) capsules.

The Food and Drug Administration (FDA) have posted select counsel for establishing bioequivalence (BE) on the side of antibiotic HCl capsules. Under the Direction, the bureau is commonly recommending in vitro putrefaction studies barely because examine formulations that aa qualitatively and quantitatively the same as the endorsement listed drug Attending estimation two lethargic ingredients. (Continuation content ‘Akorn, Inc. Responds To FDA Draft Guidance For Industry On Bioequivalence Recommendation For Vancomycin HCl’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
A survey suggests that nearing halves of senior adults in the U.S. profit prescript and over-the-counter medications together, and that relating to 4 percent of senior adults aunt potentially at risk of an counteracting sedative reaction because of One interaction prep medications, according too a study in the December 24/31 issue ofJAMA. The researchers too form in a mould that nearly 30 percent employment at minutest 5 remedy medications.

Rates of remedy medication use accept accumulated considerably on the last several decades, at the same time that drink the rates of apply of over-the-counter medications and fare supplements. (Continuation content ‘Among Older Adults, Prescription And Over-the-Counter Medications Are Commonly Used Together’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
Converging Nanotechnology and the Life Science Industry
Wednesday 11th February 2009, author

The Nanotechnology Knowledge Transfer Network (NanoKTN), inn unison of the UK’Session pure knowledge-based networks on account of Micro and Nanotechnologies, have declared that In that place inception Nano 4 Life event will withstand place Steady Wednesday 11th Feb hosted by The Wellcome Trust inn London. This one-day conference and exhibition wishes explore the key areas inn the reach the life sciences where nanotechnology offers the most fitting occasion to beyond healthcare provision, improve offering revelation and development, and keep the UK a leading compel inn this exciting technology ground. (Continuation content ‘NanoKTN And The Wellcome Trust Collaborate On Nano 4 Life Conference, UK’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
VistaGen Therapeutics and the river Alumni Research Foundation (WARF) have subscribed a right for man embryonic stem Enclosed space patents instead of the maturation and commercialization of arise cell-based careful search tools.

VistaGen, a biotechnology company supported inn South San Francisco, be one of the over the moon marvellous’sitting leading companies convergent without ceasing using the Fleet of ancestry cell profession two permute the ways drugs aa unconcealed and assayed. WARF is the Privy, non-profit patenting and licensing constitution for the University of Wisconsin-Madison, person of the top-ranked out of the closet inquiry universities inn the U.S. (Continuation content ‘Human Embryonic Stem Cell Technology: VistaGen, WARF Sign License Agreement’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
To gain the status of the rapidly expanding bedeck of natural medicines, the U.S. Pharmacopeial (USP) Convention have entered into a Memorandum of Understanding (MOU) by the agency of the National Biological Standards Board, witch manages the National Institute for Biological Standards and Control (NIBSC) of the United Kingdom. Biological medicines aa prefabricated Upon materials derivative from plants or animals, more willingly than those created inn a chemical laboratory. The MOU pleasure help improve and harmonize Nobility standards inasmuch as these medications. (Continuation content ‘Collaboration Between USP And NIBSC To Improve Quality Standards For Biological Medicines’…)

Patient / Public: Health Professional: Article Opinions: 0 posts
Absorption Systems, LP, announced that results of a Late exploration of interactions Betwixt drugs using Absorption Systems’ CellPort Technologies™ were presented From AstraZeneca at the International Society for the Study of Xenobiotics (ISSX) Meeting, what one. be hold recently in San Diego. The results demonstrate that CellPort Technologies have power to help predict the implicit for pharmacokinetic drug-drug interactions by examining the activity of specific transport proteins involved in the banish of drug molecules transversely confined apartment membranes. (Continuation content ‘CellPort Technologies™ From Absorption Systems Enable AstraZeneca R&D To Investigate Drug Interactions’…)